The role of multimodality imaging in the selection for implantable cardioverter-defibrillators in heart failure: A narrative review.

Autor: Velcea AE; Cardiology Department, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.; Cardiology and Cardiovascular Surgery Department, Emergency and University Hospital, Bucharest, Romania., Mihaila Baldea S; Cardiology Department, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.; Cardiology and Cardiovascular Surgery Department, Emergency and University Hospital, Bucharest, Romania., Nicula AI; Radiology Department, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania., Vinereanu D; Cardiology Department, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.; Cardiology and Cardiovascular Surgery Department, Emergency and University Hospital, Bucharest, Romania.
Jazyk: angličtina
Zdroj: Journal of clinical ultrasound : JCU [J Clin Ultrasound] 2022 Oct; Vol. 50 (8), pp. 1066-1072. Date of Electronic Publication: 2022 Jul 28.
DOI: 10.1002/jcu.23281
Abstrakt: Advanced pharmacologic and interventional therapies have improved survival in heart failure. Implantable cardioverter-defibrillators (ICD) have been shown to reduce mortality in patients with heart failure, but the benefit appears to be uneven in this population. We reviewed the evidence showing the benefit of ICD therapy in heart failure patients, the main issues arising from these studies, and the possible answers for a better risk stratification. In addition, we showed that multimodality imaging could improve patient selection for the implantation of ICDs, in both primary and secondary prevention, beyond the selection using only the left ventricular ejection fraction, by concentrating on arrhythmic substrate.
(© 2022 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: